Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab

Published:2020-08-19 Issue:3 Volume:31 Page:678-683
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Gon Yoshie¹,Yoshifuji Hajime¹,Nakajima Toshiki¹,Murakami Kosaku¹,Nakashima Ran¹,Ohmura Koichiro¹,Mimori Tsuneyo¹²,Terao Chikashi¹³

Affiliation:

1. Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

2. Ijinkai Takeda General Hospital, Kyoto, Japan

3. Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2020.1800560

Reference17 articles.

1. Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan

2. Takayasu Arteritis

3. Interleukin-6 and RANTES in Takayasu Arteritis

4. Tocilizumab in refractory Takayasu arteritis: A case series and updated literature review

5. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Giant Cell Arteritis and Takayasu Arteritis: Are They Similar or Different?;Indian Journal of Rheumatology;2024-09-09

2. Takayasu – Arteriitis nach COVID-19-Infektion bei einer 26 Jahre alten Patientin mit Morbus Crohn;Zeitschrift für Gastroenterologie;2024-02-28

3. A retrospective study of infantile-onset Takayasu arteritis: experience from a tertiary referral center in China;Frontiers in Cardiovascular Medicine;2024-01-31

4. Current Immunosuppressive Treatment for Takayasu Arteritis;Circulation Journal;2023-12-19

5. Advances and challenges in management of large vessel vasculitis;Rheumatology and Immunology Research;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3